Literature DB >> 24958312

DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract.

A García-Tello1, F Ramón de Fata1, G Andrés1, S Ropero2, J I López3, J C Angulo1.   

Abstract

INTRODUCTION: Lynch syndrome or hereditary nonpolyposis colorectal cancer is caused by mutations in DNA repair genes, known as mismatch repair (MMR) genes, and is associated with microsatellite instability. Urothelial carcinoma of the renal pelvis is also associated with this syndrome. These genetic abnormalities have been described in sporadic forms of upper tract urothelial carcinoma (UTUC). MATERIAL AND
METHOD: This was a descriptive study and survival analysis of a series of 80 patients with sporadic UTUC with no metastases at diagnosis (N0/Nx M0) treated exclusively with nephroureterectomy. We evaluated the expression of MMR genes (hMLH1, hPMS2, hMSH2 and hMSH6) in sections performed with tissue microarray (TMA) and their association with clinical-pathological parameters. We analyzed the prognostic value of the loss of expression of these genes in UTUC.
RESULTS: We detected no loss of MSH2 or of MSH6, but there was a loss of MLH1 in 11 cases (13.8%) and of PMS2 in 21 cases (26.3%). The expression of hMLH1 and hPMS2 were strongly associated (P<.0001), and this phenotype expression entails significant clinical implications. The loss of MLH1 was associated with a low grade (P=.02). Loss of PMS2 was associated with a lower stage (P=.05), a pushing pattern with no invasive edges (P=.008) and less angiogenesis (P=.008). The inactivation of hPMS2 or hMLH1 is an independent protective factor (HR, 0.309) and, along with the histologic grade (HR, 5.561), defines the patients' prognosis.
CONCLUSION: In our experience, the inactivation of hPMS2 or hMLH1 is an independent marker of good prognosis and occurs in a quarter of sporadic UTUC cases. The immunohistochemical study of these patients can be used to assess the screening of hidden forms of Lynch syndrome.
Copyright © 2014 AEU. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Carcinoma urotelial; DNA repair genes; Genes de reparación de ADN; Inestabilidad de microsatélites; MLH1; Microsatellite instability; PMS2; Prognosis; Pronóstico; Tracto urinario superior; Upper urinary tract; Urothelial carcinoma

Mesh:

Year:  2014        PMID: 24958312     DOI: 10.1016/j.acuro.2014.03.010

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  6 in total

Review 1.  Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma.

Authors:  Qiang Li; Aditya Bagrodia; Eugene K Cha; Jonathan A Coleman
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

2.  Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma.

Authors:  Yue Wang; Jinxia Zhang; Yunfan Wang; Shufang Wang; Yu Zhang; Qi Miao; Fei Gao; Huiying He
Journal:  Front Med       Date:  2019-04-24       Impact factor: 4.592

3.  Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.

Authors:  Holly L Harper; Jesse K McKenney; Brandie Heald; Andrew Stephenson; Steven C Campbell; Thomas Plesec; Cristina Magi-Galluzzi
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

4.  Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients.

Authors:  Jun-Yan Liu; Chen-Yue Qian; Yuan-Feng Gao; Juan Chen; Hong-Hao Zhou; Ji-Ye Yin
Journal:  Chin J Cancer       Date:  2017-01-16

5.  Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study.

Authors:  Maria Letizia Calandrella; Simona Francesconi; Cecilia Caprera; Claudia Mosillo; Claudia Caserta; Diana Giannarelli; Matteo Corsi; Serena Macrini; Annalisa Guida; Stefano Ascani; Sergio Bracarda
Journal:  BMC Cancer       Date:  2022-02-14       Impact factor: 4.430

6.  Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome.

Authors:  Bao Guan; Jie Wang; Xuesong Li; Lin Lin; Dong Fang; Wenwen Kong; Chuangyu Tian; Juan Li; Kunlin Yang; Guanpeng Han; Yucai Wu; Yuhui He; Yiji Peng; Yanfei Yu; Qun He; Shiming He; Yanqing Gong; Liqun Zhou; Qi Tang
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.